Sandoz wants Novo's sole US Prandin patent ruled invalid in a long running case
26 August 2011
Nancy Faigen
Please Login to read the full article.
26 August 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pfizer's 'non obvious' Viagra patents good until 2019 to fend off Teva in US
- Depomed sues Watson over filing of Glumetza ANDA in US
- Generic Provigil hits US market, but Mylan sues over an FDA 180-day exclusivity ruling
- Mylan fails to nix Tarceva patent leaving Astellas, Roche and Pfizer clear until 2018
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
